These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 14551502)
1. Dihydropyrimidine dehydrogenase inhibition as a strategy for the oral administration of 5-fluorouracil: utility in the treatment of advanced colorectal cancer. Schmoll HJ Anticancer Drugs; 2003 Oct; 14(9):695-702. PubMed ID: 14551502 [TBL] [Abstract][Full Text] [Related]
2. Novel oral fluoropyrimidines in the treatment of metastatic colorectal cancer. Ignoffo RJ Am J Health Syst Pharm; 1999 Dec; 56(23):2417-28; quiz 2428-9. PubMed ID: 10595802 [TBL] [Abstract][Full Text] [Related]
4. The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potential. Hoff PM Invest New Drugs; 2000 Nov; 18(4):331-42. PubMed ID: 11081569 [TBL] [Abstract][Full Text] [Related]
6. Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer. Terashima M; Fujiwara H; Takagane A; Abe K; Irinoda T; Nakaya T; Yonezawa H; Oyama K; Saito K; Kanzaki N; Ohtani S; Nemoto T; Hoshino Y; Kogure M; Gotoh M Gastric Cancer; 2003; 6 Suppl 1():71-81. PubMed ID: 12775024 [TBL] [Abstract][Full Text] [Related]
7. Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines. Usuki H; Ishimura K; Yachida S; Hagiike M; Okano K; Izuishi K; Karasawa Y; Goda F; Maeta H Gastric Cancer; 2003; 6 Suppl 1():66-70. PubMed ID: 12775023 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutations in the DPD gene, and DPD inhibitory fluoropyrimidines. Omura K Int J Clin Oncol; 2003 Jun; 8(3):132-8. PubMed ID: 12851836 [TBL] [Abstract][Full Text] [Related]
9. Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma. Meropol NJ; Niedzwiecki D; Hollis D; Schilsky RL; Mayer RJ; Cancer; 2001 Apr; 91(7):1256-63. PubMed ID: 11283924 [TBL] [Abstract][Full Text] [Related]
10. [5-fluorouracil and dihydropyrimidine dehydrogenase]. Kubota T Gan To Kagaku Ryoho; 2001 Apr; 28(4):433-9. PubMed ID: 11329775 [TBL] [Abstract][Full Text] [Related]
11. Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer. Humerickhouse RA; Dolan ME; Haraf DJ; Brockstein B; Stenson K; Kies M; Sulzen L; Ratain MJ; Vokes EE Clin Cancer Res; 1999 Feb; 5(2):291-8. PubMed ID: 10037177 [TBL] [Abstract][Full Text] [Related]
13. Clinical development of eniluracil: current status. Hohneker JA Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):52-6. PubMed ID: 9830627 [TBL] [Abstract][Full Text] [Related]
14. A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada. Maroun J; Asche C; Romeyer F; Mukherjee J; Cripps C; Oza A; Skillings J; Letarte J Pharmacoeconomics; 2003; 21(14):1039-51. PubMed ID: 13129416 [TBL] [Abstract][Full Text] [Related]
15. [Tumoral dihydropyrimidine dehydrogenase expression and efficacy of 5-fluorouracil plus leucovorin plus UFT therapy in patients with colorectal cancer]. Ishida H; Ohsawa T; Nakada H; Yokoyama M; Inokuma S; Shirakawa K; Yamada H; Hashimoto D Gan To Kagaku Ryoho; 2004 Jun; 31(6):883-7. PubMed ID: 15222105 [TBL] [Abstract][Full Text] [Related]
16. Drug delivery of oral anti-cancer fluoropyrimidine agents. Miura K; Shima H; Takebe N; Rhie J; Satoh K; Kakugawa Y; Satoh M; Kinouchi M; Yamamoto K; Hasegawa Y; Kawai M; Kanazawa K; Fujiya T; Unno M; Katakura R Expert Opin Drug Deliv; 2017 Dec; 14(12):1355-1366. PubMed ID: 28379040 [TBL] [Abstract][Full Text] [Related]
17. Regional and systemic therapies for advanced colorectal carcinoma: randomized clinical trial results. Benson AB Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):28-34. PubMed ID: 9830622 [TBL] [Abstract][Full Text] [Related]
18. Phase I and pharmacokinetic trial of weekly oral fluorouracil given with eniluracil and low-dose leucovorin to patients with solid tumors. Grem JL; Harold N; Shapiro J; Bi DQ; Quinn MG; Zentko S; Keith B; Hamilton JM; Monahan BP; Donavan S; Grollman F; Morrison G; Takimoto CH J Clin Oncol; 2000 Dec; 18(23):3952-63. PubMed ID: 11099325 [TBL] [Abstract][Full Text] [Related]
20. New options for outpatient chemotherapy--the role of oral fluoropyrimidines. Cunningham D; Coleman R Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]